Sedation for refractory symptoms of terminal cancer patients in Taiwan.
about
Palliative pharmacological sedation for terminally ill adultsSedation in palliative care - a critical analysis of 7 years experienceAttitudes towards terminal sedation: an empirical survey among experts in the field of medical ethics.Effects of opioids and sedatives on survival in an Australian inpatient palliative care population.Continuous deep sedation for patients nearing death in the Netherlands: descriptive studyThe Attitudes of Indian Palliative-care Nurses and Physicians to Pain Control and Palliative Sedation.Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China.Internists' attitudes towards terminal sedation in end of life careAddressing Palliative Sedation during Expert Consultation: A Descriptive Analysis of the Practice of Dutch Palliative Care Consultation Teams.Treatment of terminal restlessness: a review of the evidence.The relationship between pain management and psychospiritual distress in patients with advanced cancer following admission to a palliative care unit.Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer.Palliative sedation in a southern Appalachian community.The ethics of palliative sedation as a therapy of last resort.Palliative Sedation in Advanced Cancer Patients: Does it Shorten Survival Time? - A Systematic ReviewEuropean Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care.Role of haloperidol in palliative medicine: an update.The use of observational scales to monitor symptom control and depth of sedation in patients requiring palliative sedation: a systematic review.Suboptimal palliative sedation in primary care: an exploration.To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying?A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.Symptom patterns of advanced cancer patients in a palliative care unit.Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series.The use of palliative sedation: A comparison of attitudes of French-speaking physicians from Quebec and Switzerland.[Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].At-home palliative sedation for end-of-life cancer patients.A survey of the sedation practice of Portuguese palliative care teams.A Protocol for the Control of Agitation in Palliative Care.Making sense of continuous sedation in end-of-life care for cancer patients: an interview study with bereaved relatives in three European countries.Clinical Factors Associated With Adherence to the Premedication Protocol for Withdrawal of Mechanical Ventilation in Terminally Ill Patients: A 4-Year Experience at a Single Medical Center in Asia.Estimating the potential life-shortening effect of continuous sedation until death: a comparison between two approaches.Medical house officers' attitudes toward vigorous analgesia, terminal sedation, and physician-assisted suicide.Palliative sedation therapy does not hasten death: results from a prospective multicenter studyLevel of consciousness in dying patients. The role of palliative sedation: a longitudinal prospective studyFlemish palliative-care nurses' attitudes to palliative sedation: a quantitative studyESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
P2860
Q24186758-7E071BA2-B8E2-4D81-A054-4143D941CB60Q24805572-A76BDBEF-CB3C-42A1-9B0E-DF1FF867EF88Q33282213-A382BA75-5592-40F5-9AFE-3CE21E0C0EB0Q34443651-BA6F58D9-CFAE-4480-9F5D-57AE25BEFD53Q34762108-66F930D5-8208-4149-A7B1-F5B5ABD07934Q34994159-41346455-0C2B-49B3-AD93-9B1F78D56E15Q35216505-31512359-B461-4151-A59D-2A97CCA66D33Q35427167-ACB76E3B-3A63-4FAA-B080-4E40498423E7Q35753648-EC6669EC-ABAB-43B6-85E3-70465E2EB67EQ35775621-4C266CD7-B801-4984-BE94-EE507AE799B0Q35857744-B2ADD299-AE95-4FFF-A866-52B000222D3AQ36225242-99AC1080-F0D3-4C56-BE34-11139D2DBED4Q36632742-B85F2867-BECC-4352-B615-398A990E6FCCQ36702546-683EA628-8BDF-4861-8979-DB93E8DBE178Q36924213-C75C38D5-DE08-4ED1-8FCE-0EA35C450E30Q37621817-31072ECF-231B-40A7-A6B4-AE3D59CA3447Q37945595-00EEE4F9-06FE-4E09-8B5B-414F4620C2F2Q37951880-4448B227-E42E-4182-88FA-4821FB987719Q38744171-B43E7C9F-D8FC-4855-8D02-052D35A0E8D0Q38849707-696D9010-BE27-4351-A60A-4094241BBD0CQ39175922-E990CE6A-E921-4E34-A531-41C6BE4768A4Q39344359-364F76CB-EDFA-4DA9-A4C8-925B995B40ABQ41780903-F2A2DE5E-421B-40A9-864C-9F884FF64344Q42660336-AF4BCDC5-BA6E-4B46-9351-621E68F57718Q42956998-4BD2D649-F009-4BC3-851F-B905BE28C730Q43172767-672D7EE1-3AB2-42E9-80FC-71CE1F781B4DQ45789513-56EF57B4-C869-4B5C-A475-D9CF0562793FQ47370127-E6059CF9-9C08-4D9D-AC92-067724D98015Q47624475-64837FB6-777A-4D21-AA96-6BFE7F671C86Q47767539-F418A27F-56B6-462D-BD67-C1C3FED5A083Q48208406-C6B64259-9F7E-420C-9203-49E682E11972Q54732588-8954EDB3-1184-4AFE-9C6E-FFF34A9A938DQ56390381-2F494C34-EA05-4480-A0B0-788F9E7F44F2Q56774711-2B085B32-74FF-44F7-BB4E-F1F7DF3DC1C6Q57105174-DEE08530-44C1-4BF1-8F1B-1B5EF7818DE0Q59273862-CC323F69-CD71-4298-926C-EE415119761D
P2860
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
@en
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
@nl
type
label
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
@en
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
@nl
prefLabel
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
@en
Sedation for refractory symptoms of terminal cancer patients in Taiwan.
@nl
P2093
P50
P1476
Sedation for refractory symptoms of terminal cancer patients in Taiwan
@en
P2093
P304
P356
10.1016/S0885-3924(01)00286-X
P577
2001-06-01T00:00:00Z